GLP-1 Medications for Beginners: What to Know Before Your First Visit
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. Some links in this article may be affiliate links — we may earn a commission at no extra cost to you.

Quick Answer
- GLP-1 medications like [Ozempic](/medications/ozempic), [Wegovy](/medications/wegovy), and [Mounjaro](/medications/mounjaro) mimic a natural hormone that reduces appetite and helps regulate blood sugar — most patients lose 15-25% of their body weight within 12-18 months
- Brand-name GLP-1 injections cost $900-$1,400/month without insurance in 2026, but oral Wegovy launched at $149/month and compounded options run $199-$399/month
- Your first visit typically involves bloodwork, BMI assessment, and a medical history review — most providers can prescribe the same day if you qualify
- Starting doses are intentionally low to minimize side effects like nausea, and your provider will gradually increase your dose over several months
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. Some links in this article may be affiliate links — we may earn a commission at no extra cost to you.
If you've been hearing about GLP-1 medications everywhere — from your coworker's weight loss journey to headlines about celebrity prescriptions — you're not imagining it. These drugs have become the most talked-about medications in a generation. And for good reason.
But the flood of information makes it hard to separate what matters from what doesn't. Especially when you're considering taking one yourself.
This guide breaks down everything you need to know before your first appointment. No hype. No scare tactics. Just the practical information that'll help you walk into that visit prepared and confident.
What Are GLP-1 Medications and How Do They Work?
GLP-1 stands for glucagon-like peptide-1. It's a hormone your body already produces naturally. When you eat, your gut releases GLP-1 to signal your brain that you're full. It also tells your pancreas to release insulin and slows down how fast food moves through your stomach.
The medications in this class — semaglutide, tirzepatide, and newer compounds like retatrutide — are synthetic versions of this hormone. They're engineered to last much longer than the natural version, which breaks down in minutes. A single weekly injection maintains steady levels for seven days.
The Brain-Gut Connection
Here's what makes these drugs different from every diet pill that came before: they work on the actual biology of hunger. GLP-1 medications act on receptors in the hypothalamus, the part of your brain that regulates appetite. Patients consistently report that the "food noise" — that constant mental chatter about what to eat next — goes quiet.
A 2023 study published in the New England Journal of Medicine found that semaglutide reduced caloric intake by approximately 24% without patients actively trying to restrict food (Wilding et al., NEJM, 2023). That's not willpower. That's biochemistry.
Single vs. Dual-Action Medications
Not all GLP-1 medications work the same way. There are two main categories you should understand:
Single-action GLP-1 receptor agonists include semaglutide-based medications like Ozempic (approved for type 2 diabetes) and Wegovy (approved for weight management). These target the GLP-1 receptor only.
Dual-action agonists like tirzepatide — sold as Mounjaro (for diabetes) and Zepbound (for weight loss) — target both the GLP-1 and GIP receptors. GIP (glucose-dependent insulinotropic polypeptide) is another gut hormone that enhances the appetite-suppressing and metabolic effects.
Clinical trials have shown tirzepatide produces slightly greater average weight loss than semaglutide. The SURMOUNT-1 trial demonstrated up to 22.5% body weight reduction with the highest dose of tirzepatide over 72 weeks (Jastreboff et al., NEJM, 2022). For a deeper comparison, check out our Semaglutide vs Tirzepatide: Head-to-Head Comparison.
What About Next-Generation Options?
Retatrutide is a triple-action agonist currently in Phase 3 trials. It targets GLP-1, GIP, and glucagon receptors simultaneously. Early trial data from 2023 showed up to 24.2% body weight loss at 48 weeks — the highest of any obesity medication tested so far (Jastreboff et al., NEJM, 2023). It's not available yet, but it's worth knowing about as you start this journey. Your provider may mention it as a future option.
Who Qualifies for GLP-1 Medications?
This is one of the most common questions — and the answer is more straightforward than you might think.
BMI-Based Criteria
The FDA-approved criteria for GLP-1 weight management medications (Wegovy and Zepbound) are:
- BMI of 30 or higher (classified as obesity), OR
- BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea
For diabetes-specific GLP-1 medications like Ozempic and Mounjaro, you'll need a type 2 diabetes diagnosis. However, many providers prescribe these off-label for weight management when the weight-loss-specific versions are unavailable or too expensive.
Beyond the Numbers
BMI isn't a perfect measure. Your provider will also look at your overall health picture: family history, previous weight loss attempts, metabolic markers from bloodwork, and how your weight is affecting your quality of life.
According to the American Medical Association, approximately 42% of U.S. adults meet the BMI criteria for obesity as of 2024, and roughly 30% of those have at least one qualifying comorbidity (CDC National Health and Nutrition Examination Survey, 2024). That's a significant portion of the adult population who would technically qualify.
Who Should NOT Take GLP-1 Medications
There are clear contraindications your provider will screen for:
- Personal or family history of medullary thyroid carcinoma (MTC) — GLP-1 medications carry a boxed warning about thyroid C-cell tumors observed in rodent studies
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- History of pancreatitis — though emerging data suggests the risk may be lower than initially thought
- Pregnancy or plans to become pregnant — GLP-1 medications are Category X; you must stop them at least 2 months before trying to conceive
- Severe gastrointestinal disease including gastroparesis
If you have a history of eating disorders, the conversation with your provider becomes more nuanced. Some clinicians believe GLP-1 medications can help reduce binge eating behaviors, while others worry about reinforcing restrictive patterns. This is a discussion to have openly with your doctor.
What to Expect at Your First Visit
Walking into that first appointment doesn't need to be stressful. Here's exactly what happens.
Before the Appointment
Most clinics — whether in-person or telehealth — will ask you to complete intake forms covering:
- Current medications and supplements
- Medical history, including surgeries
- Family history (especially thyroid cancer, pancreatitis, and diabetes)
- Previous weight loss attempts (diets, programs, other medications)
- Your weight management goals
Some providers require recent bloodwork (within the last 3-6 months). If you don't have any, they'll order it at your visit or beforehand. Typical labs include a comprehensive metabolic panel, HbA1c (blood sugar average), thyroid function, and a lipid panel.
During the Appointment
The visit itself usually runs 20-45 minutes. Your provider will:
- Review your medical history and intake forms
- Take vitals — weight, height, blood pressure, heart rate
- Calculate your BMI and assess your body composition
- Discuss your weight history — what you've tried, what worked temporarily, what didn't
- Explain medication options — which GLP-1 might be right for you and why
- Review potential side effects — what's common, what's rare, what to watch for
- Create a dosing plan — starting dose and titration schedule
- Discuss lifestyle factors — nutrition, movement, and sleep
Same-Day Prescriptions
Here's something many beginners don't realize: most providers can prescribe the same day if you qualify. You don't always need to come back for a second visit. If your bloodwork is recent and your history is clear, you could leave with a prescription in hand.
However, your pharmacy may need time to fill it. Brand-name GLP-1 medications have experienced intermittent shortages since 2023, and while supply has stabilized significantly by 2026, some doses or brands may require a few days to source. Your provider's office can often check pharmacy availability before sending the prescription.
For help finding a prescriber, our guide on How to Find the Best GLP-1 Medications Near You covers telehealth platforms, obesity medicine specialists, and what to look for in a provider.
Understanding the Costs in 2026
Money is the elephant in the room. GLP-1 medications aren't cheap — but the landscape has shifted dramatically over the past year.
Brand-Name Pricing
Here's what you're looking at for list prices (before insurance) in 2026:
| Medication | Monthly List Price | With Insurance (typical copay) |
|---|---|---|
| Wegovy (injectable) | $1,300-$1,500 | $25-$150 |
| Ozempic | $900-$1,100 | $25-$150 |
| Zepbound | $1,000-$1,200 | $25-$200 |
| Mounjaro | $1,000-$1,200 | $25-$200 |
| Wegovy (oral tablet) | $149 (intro pricing) | Varies |
The biggest development of 2026: Novo Nordisk launched oral Wegovy tablets in January with introductory pricing at $149/month for the 1.5mg and 4mg doses. That's the lowest-cost FDA-approved GLP-1 option on the market (NBC News, 2026). While the oral version has shown somewhat lower weight loss compared to the injection — around 15% vs. 17% body weight reduction — the accessibility and price point make it a game-changer for beginners.
Insurance Coverage Updates
Insurance coverage has expanded significantly:
- Commercial insurance: Over 60% of large employer plans now cover at least one GLP-1 for weight management, up from roughly 40% in 2024 (Mercer Employer Health Benefits Survey, 2025)
- Medicare Part D: Starting July 2026, Medicare will cover GLP-1 medications for weight loss through a temporary bridge program, capping copays at $50/month through December 2026
- Medicaid: Coverage varies wildly by state — currently 23 states cover GLP-1s for weight management under Medicaid
Compounded Alternatives
Compounded versions of semaglutide and tirzepatide remain available through licensed compounding pharmacies, typically priced at $199-$399/month. These are custom-made versions using the same active ingredient. The FDA has taken enforcement actions against some compounders, so it's critical to verify your pharmacy is legitimate. Read our full breakdown: Compounded vs Brand Name GLP-1: Safety, Cost, and Legality.
Manufacturer Savings Programs
Both Novo Nordisk and Eli Lilly offer savings cards for commercially insured patients. These can reduce your copay to as low as $0-$25/month for the first 12-24 months. If you have commercial insurance, always ask about these before filling your prescription.
Side Effects: What's Common, What's Rare, and What to Do
Let's be honest about side effects. Most people experience some. Almost all of them are manageable. But you should know what you're signing up for.
The Common Side Effects (Weeks 1-8)
The most frequently reported side effects are gastrointestinal, and they're most pronounced during the first few weeks and after each dose increase:
- Nausea — affects 40-50% of patients starting semaglutide, slightly less with tirzepatide. Usually mild to moderate. Peaks during the first 2-3 days after injection and fades through the week
- Constipation or diarrhea — reported by 20-30% of patients. GLP-1 medications slow gastric emptying, which can affect bowel regularity in both directions
- Decreased appetite — this is technically the intended effect, but it can feel surprising at first. Some patients describe forgetting to eat entirely
- Injection site reactions — mild redness, itching, or bruising at the injection spot. Affects about 5-10% of patients and usually resolves within a day
- Headaches and fatigue — typically in the first 1-2 weeks as your body adjusts
How to Minimize Side Effects
Your provider will give you specific guidance, but these strategies are widely recommended:
Eat smaller, more frequent meals. A large meal on a GLP-1 medication can trigger significant nausea because your stomach is emptying more slowly. Think of it as your stomach being a smaller container now.
Stay hydrated. Aim for at least 64 ounces of water daily. Dehydration worsens nausea and constipation — and since you're eating less, you're getting less water from food.
Avoid greasy, fried, or very rich foods, especially in the first few weeks. Your tolerance for these will change. Many patients report that foods they used to love now make them feel sick. This isn't a bug — it's part of how the medication works.
Don't skip doses or increase too fast. The titration schedule exists for a reason. Jumping to a higher dose before your body has adapted is the fastest route to miserable side effects.
Rare but Serious Side Effects
These are uncommon but important to know about:
- Pancreatitis — severe, persistent abdominal pain that radiates to the back. Affects less than 1% of patients. Stop the medication and seek medical attention immediately if you experience this
- Gallbladder problems — rapid weight loss (from any cause) increases gallstone risk. Studies show gallbladder events in approximately 1.5-2.5% of GLP-1 users (Wharton et al., Lancet, 2023)
- Hypoglycemia — rare when GLP-1 is used alone for weight management, but more common if you're also taking insulin or sulfonylureas for diabetes
- Allergic reactions — extremely rare. Signs include swelling of the face, difficulty breathing, or severe rash
The "Ozempic Face" and Muscle Loss Concern
You've probably seen headlines about "Ozempic face" — the gaunt, aged appearance some patients develop from rapid facial fat loss. This is more common with significant weight loss (50+ pounds) and is related to the total weight lost, not the medication itself. Any method that produces rapid, substantial weight loss can cause similar changes.
Muscle loss is a more legitimate concern. Studies show that 25-40% of weight lost on GLP-1 medications can be lean mass (Wilding et al., NEJM, 2021). This is why resistance training and adequate protein intake (0.7-1g per pound of body weight daily) are critical while on these medications. Your provider should discuss this with you.
The Dosing and Titration Process
Understanding how dosing works removes a lot of anxiety. You don't start at the full dose. Not even close.
Why Low and Slow Matters
Every GLP-1 medication follows a titration schedule — you start at the lowest dose and increase gradually over weeks or months. This isn't optional. It's how the medications are designed to be used.
For semaglutide (Wegovy), the schedule looks like this:
- Month 1: 0.25mg weekly
- Month 2: 0.5mg weekly
- Month 3: 1.0mg weekly
- Month 4: 1.7mg weekly
- Month 5+: 2.4mg weekly (maintenance dose)
For tirzepatide (Zepbound), the schedule is similar:
- Weeks 1-4: 2.5mg weekly
- Weeks 5-8: 5mg weekly
- Then increases in 2.5mg increments every 4 weeks up to a maximum of 15mg
Each step up may bring back some mild side effects, but they're typically less intense than the initial start. Think of it like your body recalibrating at each level.
What If You Can't Tolerate a Dose Increase?
This happens. And it's completely normal. Your provider has several options:
- Stay at the current dose longer — some patients spend 6-8 weeks at a dose instead of 4 before moving up
- Split doses — some providers will have you take half the new dose for a week or two before going full strength
- Cap at a lower maintenance dose — not everyone needs the maximum dose. If you're losing weight steadily at 1.0mg of semaglutide, there's no medical requirement to push to 2.4mg
- Switch medications — some patients tolerate tirzepatide better than semaglutide, or vice versa
Self-Injection: It's Easier Than You Think
If you're needle-phobic, take a breath. GLP-1 auto-injector pens use a tiny needle (31-32 gauge, about 4mm long) that you barely feel. The process takes about 10 seconds:
- Choose your injection site — abdomen, thigh, or upper arm
- Clean the area with an alcohol swab
- Click the pen against your skin
- Hold for 5-10 seconds
- Done
Most patients say the anticipation is far worse than the actual injection. After the first 2-3 times, it becomes routine. And with the new oral Wegovy tablet, injection-free options are now available if needles are truly a dealbreaker.
Lifestyle Changes That Maximize Results
Here's the part a lot of GLP-1 content glosses over: the medication alone isn't the whole picture. Patients who combine GLP-1 medications with intentional lifestyle changes consistently achieve better results — and are more likely to maintain their weight loss long-term.
Protein: Your Most Important Nutrient
On a GLP-1 medication, your appetite drops significantly. That means every bite counts more than it used to. Protein should be your top priority at every meal. Here's why:
- Preserves muscle mass during weight loss — the single biggest factor in maintaining your metabolic rate
- Supports satiety — protein keeps you feeling full longer, working alongside the medication
- Prevents the "skinny fat" outcome where you lose weight but end up with a higher body fat percentage than when you started
The clinical recommendation for patients on GLP-1 medications is 0.7-1.0 grams of protein per pound of goal body weight daily. For someone targeting 160 pounds, that's 112-160 grams of protein per day. When you're only eating 1,200-1,500 calories, hitting that number requires planning.
Practical sources: Greek yogurt (15-20g per serving), chicken breast (26g per 3oz), eggs (6g each), protein shakes (20-30g), cottage cheese (14g per half cup), and lentils (18g per cup cooked).
Exercise: Resistance Training Over Cardio
This might surprise you. While any movement is good, resistance training (weight lifting, bodyweight exercises, resistance bands) is significantly more important than cardio for GLP-1 patients.
A 2024 study from the University of Pennsylvania found that GLP-1 patients who performed resistance training 3x per week retained 85% of their lean mass during weight loss, compared to 62% in the sedentary group (Jensen et al., Obesity, 2024). The cardio-only group fell in between at 71%.
You don't need to become a powerlifter. Two to three sessions per week of basic compound movements — squats, deadlifts, presses, rows — is enough. If you've never lifted before, even a few sessions with a trainer to learn proper form is a worthwhile investment.
Sleep and Stress
Poor sleep and chronic stress both increase ghrelin (the hunger hormone) and cortisol, which can partially counteract the appetite-suppressing effects of GLP-1 medications. Aim for 7-9 hours of sleep. This isn't wellness fluff — it's practical advice that directly affects your results.
Hydration and Alcohol
Alcohol tolerance often changes dramatically on GLP-1 medications. Many patients report feeling intoxicated faster and experiencing worse hangovers. The slowed gastric emptying means alcohol sits in your stomach longer and may be absorbed differently. Most providers recommend reducing alcohol intake, especially in the first few months.
Water intake becomes critical because you're eating less (and therefore getting less water from food). Dehydration can worsen constipation, headaches, and fatigue — side effects you're already at higher risk for. Keep a water bottle with you and aim for 64-80 ounces daily.
What Results to Realistically Expect
Setting realistic expectations prevents frustration — and helps you recognize genuine progress.
The Weight Loss Timeline
Weight loss on GLP-1 medications doesn't follow a straight line. Here's a realistic timeline based on clinical trial data and real-world outcomes:
Weeks 1-4 (starting dose): Most patients lose 2-5 pounds. Some of this is water weight. Some patients don't lose anything yet — that's normal at the lowest dose. The medication is still building up in your system.
Months 2-3 (dose escalation): Weight loss typically accelerates. Average loss of 1-2 pounds per week. Appetite suppression becomes more noticeable. This is when most patients have their "aha" moment — realizing they can walk past the break room donuts without a second thought.
Months 4-8 (approaching maintenance dose): The most active weight loss phase. Patients on semaglutide 2.4mg average about 15-17% total body weight loss by this point. Tirzepatide patients at higher doses average 18-22% (Jastreboff et al., NEJM, 2022).
Months 9-16 (plateau and stabilization): Weight loss slows. This is normal and expected — not a sign the medication stopped working. Your body has a new, lower set point and is defending it. Total average weight loss in clinical trials: 15-17% for semaglutide and 20-22.5% for tirzepatide at maximum doses.
Beyond 16 months: Weight typically stabilizes. Continued use maintains the weight loss. Studies show that approximately 67% of patients who stop GLP-1 medications regain two-thirds of their lost weight within one year (Wilding et al., Diabetes, Obesity and Metabolism, 2022).
Non-Scale Victories
Weight is just one metric. Many patients report improvements that matter more to their daily lives:
- Blood pressure reduction — average decrease of 5-8 mmHg systolic
- HbA1c improvement — even in non-diabetic patients, blood sugar regulation improves
- Sleep quality — particularly for those with sleep apnea, which often resolves or improves significantly
- Joint pain reduction — less weight means less mechanical stress on knees, hips, and ankles
- Improved cholesterol profiles — LDL tends to decrease while HDL increases
- Mental health improvements — reduced food anxiety, improved body image, and increased physical activity all contribute
When It Doesn't Work as Expected
About 10-15% of patients are classified as "non-responders" — they lose less than 5% of their body weight on GLP-1 medications. If that's you, it doesn't mean you've failed. It may mean:
- The dose isn't high enough yet (patience through titration matters)
- A different GLP-1 medication might work better for your biology
- There's an underlying condition affecting your response (thyroid dysfunction, PCOS, certain medications that promote weight gain)
- Lifestyle factors need adjustment
Your provider should reassess at the 3-month and 6-month marks. If you're not seeing meaningful progress by month 6 on an adequate dose, a medication switch or additional evaluation is warranted.
For a detailed comparison of your medication options, read Wegovy vs Ozempic: Cost, Results, and Which to Choose.
Choosing Between Medications: A Practical Framework
With several GLP-1 options on the market, picking the right one can feel overwhelming. Here's how to think about it.
Decision Factors That Actually Matter
Insurance coverage is the starting point for most people. Check which GLP-1 medications your plan covers before falling in love with a specific brand. Call the number on the back of your insurance card and ask: "Do you cover semaglutide or tirzepatide for weight management? What tier is it? Do I need prior authorization?"
Your primary goal shapes the choice. If you have type 2 diabetes AND want weight loss, Mounjaro or Ozempic may be ideal because they're approved for diabetes (which often gets better insurance coverage). If weight management is your sole focus and you don't have diabetes, Wegovy or Zepbound are the FDA-approved options.
Needle comfort level now matters more than ever. With oral Wegovy available in 2026, you have an injection-free option for the first time. The trade-off: slightly less weight loss on average compared to the injectable version.
Budget without insurance pushes many patients toward compounded versions ($199-$399/month) or the new oral Wegovy ($149/month at intro pricing). Both are significantly cheaper than brand-name injectables at $900-$1,400/month.
A Quick Comparison
| Factor | Semaglutide (Ozempic/Wegovy) | Tirzepatide (Mounjaro/Zepbound) |
|---|---|---|
| Mechanism | GLP-1 only | GLP-1 + GIP (dual) |
| Average weight loss | 15-17% | 20-22.5% |
| Injection frequency | Once weekly | Once weekly |
| Oral option available? | Yes (2026) | Not yet |
| Time on market | Since 2017/2021 | Since 2022/2023 |
| Compounded available? | Yes | Yes |
Talk to Your Provider, Not the Internet
Social media is full of people swearing that one medication is "better" than another. But GLP-1 response is highly individual. Some patients who barely respond to semaglutide see dramatic results on tirzepatide, and vice versa. Your provider can help match the right medication to your specific health profile, insurance situation, and goals.
Frequently Asked Questions
How long do I need to stay on a GLP-1 medication?
Current evidence suggests GLP-1 medications work best as long-term or indefinite therapy for most patients. The SELECT trial (2023) and subsequent studies show that discontinuing GLP-1 medications leads to significant weight regain — approximately two-thirds of lost weight returns within 12 months for most patients. Your provider may discuss dose reduction strategies or periodic breaks, but the expectation should be that this is an ongoing treatment similar to blood pressure or cholesterol medication. Some patients do successfully transition off with maintained lifestyle changes, but they are the exception rather than the rule.
Can I drink alcohol while taking GLP-1 medications?
There's no absolute prohibition, but most providers recommend caution, especially in the early months. GLP-1 medications slow gastric emptying, which can change how quickly alcohol affects you. Many patients report feeling intoxicated faster on fewer drinks and experiencing intensified hangover symptoms. Alcohol is also calorie-dense and can trigger poor food choices that work against your goals. If you do drink, start slowly to gauge your new tolerance — one drink where you'd normally have two — and see how your body responds before having more.
Will my insurance require prior authorization?
Almost certainly, yes. Prior authorization (PA) for GLP-1 medications is standard across most insurance plans in 2026. Your provider's office will handle the paperwork, which typically requires documenting your BMI, comorbidities, and previous weight loss attempts. Approval can take 3-14 business days. If denied, your provider can file an appeal — first-round denials are common but often overturned. Ask your provider's office about their PA success rate and average turnaround time before your visit so you can set expectations.
What happens if there's a shortage and I can't get my medication?
GLP-1 supply shortages peaked in 2023-2024 and have improved substantially by 2026, though intermittent disruptions still occur for specific doses. If you can't fill your prescription, contact your provider immediately. Options include temporarily using a different dose, switching to a different GLP-1 brand, or using a compounded version as a bridge. Missing one week typically doesn't cause significant weight regain, but extended gaps (3+ weeks) can lead to return of appetite and some weight rebound. Your provider should have a contingency plan in place.
Do I need to follow a specific diet on GLP-1 medications?
No single prescribed diet is required, but strategic eating makes a significant difference in your outcomes. The core principles: prioritize protein (0.7-1g per pound of goal body weight), eat smaller portions because your stomach empties slower, stay well-hydrated, and minimize ultra-processed foods that are calorie-dense but nutritionally empty. Many patients naturally gravitate toward whole foods because highly processed and greasy foods tend to cause more nausea on GLP-1 medications. Think of it less as a "diet" and more as your appetite finally aligning with what your body actually needs.
Related Reading
- Semaglutide vs Tirzepatide: Head-to-Head Comparison [2026]
- How to Find the Best GLP-1 Medications Near You: 2026 Guide
- Compounded vs Brand Name GLP-1: Safety, Cost, and Legality [2026]
-- The The GLP-1 Daily Team
On Google
Get our answers in your Google results.
Add The GLP-1 Daily as a preferred source and Google will surface our reporting more often — in Top Stories and AI answers, marked with a preferred badge. One tap, free, undo anytime.
Add us as a preferred sourceOpens Google's source preferences for theglp1daily.com. No sign-up with us — it's a Google setting.